Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

July 1, 2022 | John Murphy | Leave a Comment

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

Authors: Chansavath Phetsouphanh, David R. Darley, Daniel B. Wilson, Annett Howe, C. Mee Ling Munier, Sheila K. Patel, Jennifer A. Juno, Louise M. Burrell, Stephen J. Kent, Gregory J. Dore, Anthony D. Kelleher & Gail V. Matthews Nature Immunology volume 23, pages210–216 (2022) June 30,…[...]

June 30, 2022 | John Murphy | Leave a Comment

New Clues To Long Covid: Prolonged Inflammatory Response

Authors: William A. Haseltine January 2922 Posted July 2022 Forbes For many Covid-19 patients, the end of the acute stage of infection is only the beginning of another difficult experience:…[...]

June 15, 2022 | John Murphy | Leave a Comment

CDC Says Moderna’s Covid-19 Vaccine Poses Greater Heart Inflammation Risk Than Pfizer

Authors: im Hoft Published June 14, 2022 Gateway Pundit Moderna’s COVID-19 vaccine may have a higher risk of heart inflammation than the Pfizer shot based on recent data, the U.S.…[...]

June 11, 2022 | John Murphy | Leave a Comment

COVID-19: Understanding long COVID

Authors: Emory News Center For some individuals, the road to recovery from COVID-19 is long. While most people recover from mild COVID-19 symptoms over the course of one to two…[...]

May 29, 2022 | John Murphy | Leave a Comment

Coronavirus: Kidney Damage Caused by COVID-19

Authors: C. John Sperati, M.D., M.H.S. Posted May 28, 2022 John's Hopkins Health COVID-19 Kidney Damage: A Known Complication Some people suffering with severe cases of COVID-19 will show signs…[...]

April 26, 2022 | John Murphy | Leave a Comment

Vaccinated Up to 15X MORE LIKELY Than Unvaxxed to Develop Heart Inflammation Requiring Hospitalization: Peer Reviewed Study

Authors: Julian Conradson Published April 25, 2022 at 4:14pm A new study out of Europe has revealed that cases of heart inflammation that required hospitalization were much more common among vaccinated individuals…[...]

February 24, 2022 | John Murphy | Leave a Comment

Colchicine: A Possible COVID-19 Long haul Cardiac Therapy

Last Updated: December 16, 2021 Last Updated: December 16, 2021 Colchicine is an anti-inflammatory drug that is used to treat a variety of conditions, including gout, recurrent pericarditis, and familial Mediterranean fever.1 Recently,…[...]

February 15, 2022 | John Murphy | Leave a Comment

Management of urticaria in COVID-19 patients: A systematic review

Authors: Eyad Abuelgasim,Ann Christine Modaragamage Dona,Rajan Singh Sondh,Amer Harky First published: 28 September 2020 https://doi.org/10.1111/dth.14328 Abstract The global pandemic COVID-19 has resulted in significant global morbidity, mortality and increased healthcare demands.…[...]

January 22, 2022 | John Murphy | Leave a Comment

Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives

Authors: Giovanni Genovese,a,bChiara Moltrasio,a,cEmilio Berti,a,b and Angelo Valerio Marzanoa,b,* Dermatology. 2020 Nov 24 : 1–12.Published online 2020 Nov 24. doi: 10.1159/000512932PMCID: PMC7801998PMID: 33232965 Abstract Background Coronavirus disease-19 (COVID-19) is an ongoing global pandemic caused by the “severe…[...]

January 18, 2022 | John Murphy | Leave a Comment

COVID-19 and chronic kidney disease: a comprehensive review

Authors: Inah Maria D. Pecly,1Rafael B. Azevedo,1Elizabeth S. Muxfeldt,1,2Bruna G. Botelho,1Gabriela G. Albuquerque,1Pedro Henrique P. Diniz,1Rodrigo Silva,1 and Cibele I. S. Rodrigues3 J Bras Nefrol. 2021 Jul-Sep; 43(3): 383–399.Published online 2021 Apr 9. doi: 10.1590/2175-8239-JBN-2020-0203PMCID: PMC8428633PMID: 33836039…[...]